Published in J Immunol on January 18, 2010
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Th1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic pain. PLoS One (2013) 1.53
Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. Int J Nephrol (2012) 1.31
Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol (2012) 1.18
A novel mouse model of Schistosoma haematobium egg-induced immunopathology. PLoS Pathog (2012) 1.11
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.10
Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection. Infect Immun (2012) 1.04
Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio (2011) 1.04
Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host Microbe (2013) 1.01
Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect Immun (2012) 0.95
Investigating the contribution of IL-17A and IL-17F to the host response during Escherichia coli mastitis. Vet Res (2015) 0.87
The nature of immune responses to urinary tract infections. Nat Rev Immunol (2015) 0.86
Development of a Vaccine against Escherichia coli Urinary Tract Infections. Pathogens (2015) 0.84
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
A new mouse model for female genital schistosomiasis. PLoS Negl Trop Dis (2014) 0.80
Differential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defense. PLoS One (2012) 0.79
Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Pathogens (2016) 0.79
Immune mediators of chronic pelvic pain syndrome. Nat Rev Urol (2014) 0.78
Diagnosis and inflammatory response of patients with candiduria. Mycoses (2012) 0.78
Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med (2016) 0.77
Comparative tissue transcriptomics reveal prompt inter-organ communication in response to local bacterial kidney infection. BMC Genomics (2011) 0.77
Innate Immune Responses to Bladder Infection. Microbiol Spectr (2016) 0.75
Pathogenic Escherichia coli. Nat Rev Microbiol (2004) 17.81
Interleukin-17 family members and inflammation. Immunity (2004) 16.16
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity (2002) 9.29
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity (2009) 8.20
Induction and effector functions of T(H)17 cells. Nature (2008) 7.75
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity (2009) 6.24
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55
IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol (2006) 5.27
A toll-like receptor that prevents infection by uropathogenic bacteria. Science (2004) 5.26
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol (2000) 4.26
IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol (2007) 4.23
T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell (1993) 4.18
Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol (2007) 4.11
Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog (2008) 4.05
The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol (2000) 3.71
Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol (2002) 3.64
TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol (2006) 3.44
Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol (2009) 3.23
The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe (2009) 3.07
Urologic diseases in America Project: analytical methods and principal findings. J Urol (2005) 2.87
Diversity, rearrangement, and expression of murine T cell gamma genes. Cell (1986) 2.81
IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol (2007) 2.74
Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun (2005) 2.66
Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest (1993) 2.65
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol (2008) 2.49
An overview of IL-17 function and signaling. Cytokine (2008) 2.38
Induction, function and regulation of IL-17-producing T cells. Eur J Immunol (2008) 2.38
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis (1999) 2.23
Positive selection of dendritic epidermal gammadelta T cell precursors in the fetal thymus determines expression of skin-homing receptors. Immunity (2004) 2.19
Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14
Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun (2007) 2.08
Recognition by gamma/delta T cells. Annu Rev Immunol (1996) 1.82
Th17 cytokines and mucosal immunity. Immunol Rev (2008) 1.80
Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med (2009) 1.72
Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev (1995) 1.69
IL-17A is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance. Int Immunol (2008) 1.67
IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol (2002) 1.64
Self heat shock and gamma delta T-cell reactivity. Proc Natl Acad Sci U S A (1990) 1.63
Reaction of the vesical wall to bacterial penetration: resistance to attachment, desquamation, and leukocytic activity. Invest Urol (1977) 1.63
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol (2007) 1.57
Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol (2008) 1.50
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun (2004) 1.48
IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J Immunol (2009) 1.46
Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism. Infect Immun (1988) 1.42
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J Immunol (2008) 1.42
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med (2009) 1.41
A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J Immunol (2009) 1.39
Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes. J Exp Med (1993) 1.36
Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol (2006) 1.32
Antigen-specific responses accelerate bacterial clearance in the bladder. J Immunol (2006) 1.32
Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect Immun (2006) 1.23
G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol (2008) 1.22
Of mice and man: TLR11 (finally) finds profilin. Trends Immunol (2005) 1.21
IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol (2006) 1.20
TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest (2008) 1.15
Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics (2005) 1.12
Structural analysis of human beta-defensin-1 and its significance in urinary tract infection. Nephron (2000) 1.11
Susceptibility of immunodeficient gene-knockout mice to urinary tract infection. J Urol (1999) 1.09
IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis. J Immunol (2009) 1.08
Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur J Clin Invest (2005) 0.96
The role of the epithelial cell in Escherichia coli induced neutrophil migration into the urinary tract. Eur Respir J (1996) 0.96
Characterization of T-cell receptor gamma delta T cells appearing at the early phase of murine Listeria monocytogenes infection. Immunology (1993) 0.94
The urinary tract response to entry of pathogens. World J Urol (1999) 0.92
Expression of the T cell receptor delta-chain repertoire in mouse lymph node. Immunol Cell Biol (1996) 0.80
[Tissue gamma/delta T cells in experimental urinary tract infection relationship between other immuno-competent cells]. Kansenshogaku Zasshi (1994) 0.79
[Study on local immune response in Escherichia coli-induced experimental urinary tract infection in mice--infiltration of Ia-positive cells, macrophages, neutrophils, T cells and B cells]. Kansenshogaku Zasshi (1992) 0.78
TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med (2008) 3.62
Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol (2007) 2.50
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47
Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14
The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood (2010) 1.97
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol (2006) 1.83
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76
Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67
Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60
Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56
Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun (2002) 1.56
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 1.55
Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol (2009) 1.51
Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50
The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49
Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44
Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun (2011) 1.41
Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect Immun (2004) 1.36
Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol (2009) 1.34
Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun (2005) 1.32
Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J Clin Microbiol (2006) 1.29
MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection. J Immunol (2007) 1.26
Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol (2008) 1.25
complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol (2007) 1.24
Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun (2002) 1.22
In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun (2002) 1.21
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med (2010) 1.21
Transcriptome of swarming Proteus mirabilis. Infect Immun (2010) 1.19
Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect Immun (2003) 1.16
Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol (2011) 1.15
Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells. PLoS Pathog (2013) 1.14
Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol (2002) 1.14
Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun (2006) 1.14
CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur J Immunol (2010) 1.13
Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology. Nat Med (2012) 1.11
Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog (2013) 1.10
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.10
Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis (2013) 1.09
Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol (2008) 1.08
Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio (2010) 1.07
A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol Microbiol (2008) 1.07
Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun (2004) 1.07
Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun (2012) 1.06
Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae. J Bacteriol (2008) 1.04
Helicobacter pylori HP1512 is a nickel-responsive NikR-regulated outer membrane protein. Infect Immun (2006) 1.04
The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J Med Microbiol (2007) 1.04
Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio (2011) 1.04
Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infect Immun (2006) 1.03
The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol (2002) 1.03
The chemokine CCL6 promotes innate immunity via immune cell activation and recruitment. J Immunol (2007) 1.03
Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun (2004) 1.03
B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. PLoS One (2008) 1.01
Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect Immun (2010) 1.01
PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect Immun (2008) 1.00
Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma. PLoS Comput Biol (2010) 1.00
The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol (2011) 0.99
Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun (2010) 0.99
Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect Immun (2002) 0.98
Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis (2009) 0.98
Determination of target sequence bound by PapX, repressor of bacterial motility, in flhD promoter using systematic evolution of ligands by exponential enrichment (SELEX) and high throughput sequencing. J Biol Chem (2011) 0.96
Vaccines for Proteus mirabilis in urinary tract infection. Int J Antimicrob Agents (2002) 0.96
Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogues in Proteus mirabilis. Mol Microbiol (2008) 0.96
FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio (2012) 0.95
Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun (2008) 0.95
Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes. J Leukoc Biol (2007) 0.95
Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection. MBio (2012) 0.94
Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect Immun (2009) 0.94
Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun (2013) 0.93
Uropathogenic Escherichia coli strains generally lack functional Trg and Tap chemoreceptors found in the majority of E. coli strains strictly residing in the gut. J Bacteriol (2006) 0.92
Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infect Immun (2011) 0.91
The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol (2008) 0.91
Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infect Immun (2009) 0.91
Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun (2011) 0.90
Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection. Infect Immun (2008) 0.90
Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J Bacteriol (2008) 0.90
UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections. Infect Immun (2003) 0.89
Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology. J Immunol (2010) 0.88